Trial Profile
A Pilot Study of Double-blind Comparison of Vilazodone to Paroxetine in Geriatric Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Vilazodone (Primary) ; Paroxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- 25 Apr 2017 Results published in the Pharmacopsychiatry.
- 01 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Dec 2014 Planned end date changed from 1 Dec 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov.